MAb3E10: Began a Phase I study

MedClone Inc., Los Angeles Product: MAb3E10, therapeutic vaccine using a lupus-related monoclonal antibody Indication: Treat nephritis associated with systemic lupus erythematosus (SLE) Status: Bega...